Nirmidas Biotech, Inc.

Nirmidas Biotech was founded in September of 2013. We are a member of the Janssen Labs (JLABS) and QB3 programs, the Stanford StartX Med Program, and the MIT Industrial Liaison Program (MIT ILP). We are also a StartX Med COVID-19 Task Force Company since early 2020. Based in California’s Silicon Valley, Nirmidas is an innovative biotechnology company that develops and commercializes products for diagnostics and imaging including test kits, NIR-II/SWIR probes and dyes, and NIR scanners and in vivo NIR-II imaging instruments. Nirmidas integrates chemistry, nanoscience, biology, bio-engineering, and optical imaging with unique core competences in near-infrared fluorescence in the 800-1700 nm range. The pGOLD™assay system has already been implemented in a CLIA lab for clinical testing. It offers a powerful research tool for new biomarker discovery and drug development. It has been utilized by numerous researchers worldwide.